» Articles » PMID: 26017136

The Biphasic Effects of Oxidized-low Density Lipoprotein on the Vasculogenic Function of Endothelial Progenitor Cells

Overview
Journal PLoS One
Date 2015 May 29
PMID 26017136
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Late-outgrowth endothelial progenitor cells (EPCs) are stress-resistant and responsible for reparative functions in the cardiovascular system. Oxidized-LDL (oxLDL) plays a critical role in cardiovascular disease pathogenesis. However, it is largely unknown what the impacts of oxLDL are on late-outgrowth EPCs. This study aimed to investigate the concentration-related effects of oxLDL on EPC functions and related angiogenesis, in vitro and in vivo. In this study, early and late-outgrowth EPCs were generated from circulating human mononuclear cells. oxLDL may regulate EPC vasculogenic function via the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). Lower concentrations (5 μg/mL) of oxLDL can potentiate EPC tube formation in vitro and in vivo by activating eNOS mechanisms, which are mediated by p38 MAPK- and SAPK/JNK-related pathways. Higher concentrations of oxLDL (10-50 μg/mL) impaired EPC function via the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase pathways and consequent inhibition of eNOS activity, which could be reversed by anti-oxidants (diphenylene iodonium and apocynin) and gp91phox siRNA. In conclusion, oxLDL has concentration-dependent biphasic effects on human late-outgrowth EPC tube formation in vitro and in vivo.

Citing Articles

Diabetic dyslipidemia impairs coronary collateral formation: An update.

Shen Y, Wang X, Dai Y, Wang Y, Zhang R, Lu L Front Cardiovasc Med. 2022; 9:956086.

PMID: 36072863 PMC: 9441638. DOI: 10.3389/fcvm.2022.956086.


Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches.

Peyter A, Armengaud J, Guillot E, Yzydorczyk C Int J Mol Sci. 2021; 22(13).

PMID: 34206404 PMC: 8267891. DOI: 10.3390/ijms22136667.


Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling.

Singla B, Lin H, Ahn W, White J, Csanyi G Antioxidants (Basel). 2021; 10(2).

PMID: 33672291 PMC: 7926875. DOI: 10.3390/antiox10020331.


Exogenous endothelial progenitor cells reached the deficient region of acute cerebral ischemia rats to improve functional recovery via Bcl-2.

Hong Y, Yu Q, Kong Z, Wang M, Zhang R, Li Y Cardiovasc Diagn Ther. 2020; 10(4):695-704.

PMID: 32968626 PMC: 7487376. DOI: 10.21037/cdt-20-329.


Oxidized LDL Modify the Human Adipocyte Phenotype to an Insulin Resistant, Proinflamatory and Proapoptotic Profile.

Santiago-Fernandez C, Martin-Reyes F, Tome M, Ocana-Wilhelmi L, Rivas-Becerra J, Tatzber F Biomolecules. 2020; 10(4).

PMID: 32244787 PMC: 7226150. DOI: 10.3390/biom10040534.


References
1.
Holvoet P, Van Cleemput J, Collen D, Vanhaecke J . Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 2000; 20(3):698-702. DOI: 10.1161/01.atv.20.3.698. View

2.
Gothert J, Gustin S, van Eekelen J, Schmidt U, Hall M, Jane S . Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood. 2004; 104(6):1769-77. DOI: 10.1182/blood-2003-11-3952. View

3.
Wang X, Chen J, Tao Q, Zhu J, Shang Y . Effects of ox-LDL on number and activity of circulating endothelial progenitor cells. Drug Chem Toxicol. 2004; 27(3):243-55. DOI: 10.1081/dct-120037505. View

4.
CASTELLI W . Epidemiology of coronary heart disease: the Framingham study. Am J Med. 1984; 76(2A):4-12. DOI: 10.1016/0002-9343(84)90952-5. View

5.
Martin M, Hulley S, Browner W, Kuller L, Wentworth D . Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986; 2(8513):933-6. DOI: 10.1016/s0140-6736(86)90597-0. View